Dopharma's Dexa-ject for pigs receives EU marketing authorisation
Dopharma, a family-owned Dutch manufacturer of veterinary pharmaceuticals, has obtained three new marketing authorisations in the EU, among them Dexa-ject, an inflammation treatment for pigs.
Dexa-ject 2 mg/ml is a dexamethasone injection for use in pigs, cattle, horses, dogs and cats. It is indicated for treatment of inflammatory or allergic conditions. Dexa-ject 2 mg/ml will be available in 15 EU countries (BE, DK, DE, EE, ES,FR, GB, HU, IE, IT, LT, LV, PL, RO, SE).
To comment, login here
Or register to be able to comment.